-
1
-
-
0025998519
-
A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of "functional" psychosis
-
Squires, R. F., and Saederup, E. 1991. A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis. Neurochem. Res. 16:1099-1111.
-
(1991)
Neurochem. Res.
, vol.16
, pp. 1099-1111
-
-
Squires, R.F.1
Saederup, E.2
-
2
-
-
0023874366
-
35S-t-butylbicyclophosphorothionate binding sites in rat brain
-
35S-t-butylbicyclophosphorothionate binding sites in rat brain. Brain Res. 441: 15-22.
-
(1988)
Brain Res.
, vol.441
, pp. 15-22
-
-
Squires, R.F.1
Saederup, E.2
-
3
-
-
0026612363
-
A receptor subunit mRNAs in the rat brain. 1. Telencephalon, diencephalon, mesencephalon
-
A receptor subunit mRNAs in the rat brain. 1. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12:1040-1062.
-
(1992)
J. Neurosci.
, vol.12
, pp. 1040-1062
-
-
Wisden, W.1
Laurie, D.J.2
Monyer, H.3
Seeburg, P.H.4
-
4
-
-
0028977843
-
A-receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits
-
A-receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359:154-194.
-
(1995)
J. Comp. Neurol.
, vol.359
, pp. 154-194
-
-
Fritschy, J.-M.1
Mohler, H.2
-
6
-
-
0028970778
-
Subtype specificity of γ-aminobutyric acid type A receptor antagonism by Clozapine
-
Korpi, E. R., Wong, G., and Lüddens, H. 1995. Subtype specificity of γ-aminobutyric acid type A receptor antagonism by Clozapine. Nauyn-Schmied. Arch. Pharmacol. 352:365-373.
-
(1995)
Nauyn-Schmied. Arch. Pharmacol.
, vol.352
, pp. 365-373
-
-
Korpi, E.R.1
Wong, G.2
Lüddens, H.3
-
7
-
-
0031027977
-
Clozapine and some other antipsychotic drugs may preferentially block the same subset of GABAA receptors
-
Squires, R. F., and Saederup, E. 1997. Clozapine and some other antipsychotic drugs may preferentially block the same subset of GABAA receptors. Neurochem. Res. 22:151-162.
-
(1997)
Neurochem. Res.
, vol.22
, pp. 151-162
-
-
Squires, R.F.1
Saederup, E.2
-
9
-
-
0020646504
-
35S]t-Butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to γ-aminobutyric acid-A and ion recognition sites
-
35S]t-Butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to γ-aminobutyric acid-A and ion recognition sites. Mol. Pharmacol. 23:326-336.
-
(1983)
Mol. Pharmacol.
, vol.23
, pp. 326-336
-
-
Squires, R.F.1
Casida, J.E.2
Richardson, M.3
Saederup, E.4
-
11
-
-
0019463342
-
A steroid derivative, R 5135, antagonizes the GABA/benzodiazepine receptor interaction
-
Hunt, P., and Clements-Jewery, S. 1981. A steroid derivative, R 5135, antagonizes the GABA/benzodiazepine receptor interaction. Neuropharmacology 20:357-361.
-
(1981)
Neuropharmacology
, vol.20
, pp. 357-361
-
-
Hunt, P.1
Clements-Jewery, S.2
-
12
-
-
0021846504
-
Treatment of negative symptoms
-
Carpenter, Jr., W. T., Heinrichs, D. W., and Alphs, L. D. 1985. Treatment of negative symptoms. Schizophrenia Bull. 11:440-452.
-
(1985)
Schizophrenia Bull.
, vol.11
, pp. 440-452
-
-
Carpenter Jr., W.T.1
Heinrichs, D.W.2
Alphs, L.D.3
-
13
-
-
0025910277
-
Negative symptoms of schizophrenia: The need for conceptual clarity
-
Tandon, R., and Greden, J. F. 1991. Negative symptoms of schizophrenia: The need for conceptual clarity. Biol. Psychiat. 30:321-325.
-
(1991)
Biol. Psychiat.
, vol.30
, pp. 321-325
-
-
Tandon, R.1
Greden, J.F.2
-
15
-
-
0027815147
-
Positive and negative symptoms covary during clozapine treatment in schizophrenia
-
Tandon, R., Goldman, R., DeQuardo, J. R., Goldman, M., Perez, M., and Jibson, M. 1993. Positive and negative symptoms covary during clozapine treatment in schizophrenia. J. Psychiat. Res. 27: 341-347.
-
(1993)
J. Psychiat. Res.
, vol.27
, pp. 341-347
-
-
Tandon, R.1
Goldman, R.2
DeQuardo, J.R.3
Goldman, M.4
Perez, M.5
Jibson, M.6
-
16
-
-
0028044565
-
Clozapine's effect on negative symptoms in treatment-refractory schizophrenics
-
Miller, D. D., Perry, P. J., Cadoret, R. J., and Andreasen, N. C. 1994. Clozapine's effect on negative symptoms in treatment-refractory schizophrenics. Compr. Psychiat. 35:8-15.
-
(1994)
Compr. Psychiat.
, vol.35
, pp. 8-15
-
-
Miller, D.D.1
Perry, P.J.2
Cadoret, R.J.3
Andreasen, N.C.4
-
17
-
-
0027938035
-
Distribution, prevalence, and drug binding profile of γ-aminobutyric acid type A receptor subtypes differing in the γ-subunit variant
-
Benke, D., Fritschy, J.-M., Trzeciak, A., Bannwarth, W., and Mohler, H. 1994. Distribution, prevalence, and drug binding profile of γ-aminobutyric acid type A receptor subtypes differing in the γ-subunit variant. J. Biol. Chem. 269:27100-27107.
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 27100-27107
-
-
Benke, D.1
Fritschy, J.-M.2
Trzeciak, A.3
Bannwarth, W.4
Mohler, H.5
-
18
-
-
0028181830
-
A receptors containing the al subunit to neurochemically distinct subpopulations of rat hippocampal interneurons
-
A receptors containing the al subunit to neurochemically distinct subpopulations of rat hippocampal interneurons. Eur. J. Neurosci. 6:837-853.
-
(1994)
Eur. J. Neurosci.
, vol.6
, pp. 837-853
-
-
Gao, B.1
Fritschy, J.M.2
-
19
-
-
0026512275
-
γ-Aminobutyric acid-containing basal forebrain neurons innervate inhibitory interneurons in the neocortex
-
Freund, T. F., and Meskenaite, V. 1992. γ-Aminobutyric acid-containing basal forebrain neurons innervate inhibitory interneurons in the neocortex. Proc. Nat. Acad. Sci. USA. 89:738-742.
-
(1992)
Proc. Nat. Acad. Sci. USA
, vol.89
, pp. 738-742
-
-
Freund, T.F.1
Meskenaite, V.2
-
20
-
-
0001875379
-
Drugs and the Treatment of Psychiatric Disorders, Psychosis and Anxiety
-
Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., and Gilman, A. G. (eds.)
-
Baldessarini, R. J. 1996. Drugs and the Treatment of Psychiatric Disorders, Psychosis and Anxiety. Pages 399-430, in Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., and Gilman, A. G. (eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition.
-
(1996)
Goodman & Gilman's the Pharmacological Basis of Therapeutics, Ninth Edition
, pp. 399-430
-
-
Baldessarini, R.J.1
-
21
-
-
0030855293
-
Methylene blue adjuvant therapy of schizophrenia
-
Deutsch, S. I., Rosse, R. B., Schwartz, B. L., Fay-McCarthy, M., Rosenberg, P. B., and Fearing, K. 1997. Methylene blue adjuvant therapy of schizophrenia. Clin. Neuropharmacol. 20:357-363.
-
(1997)
Clin. Neuropharmacol.
, vol.20
, pp. 357-363
-
-
Deutsch, S.I.1
Rosse, R.B.2
Schwartz, B.L.3
Fay-McCarthy, M.4
Rosenberg, P.B.5
Fearing, K.6
|